{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:05:59Z","timestamp":1790622359067,"version":"4.1.0"},"reference-count":32,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Lassa fever is a hemorrhagic disease caused by Lassa fever virus (LV). Although the precise host defense mechanism(s) that affords protection against LV is not completely understood, cellular immunity mediated by cytotoxic T lymphocytes (CTLs) plays a pivotal role in controlling viral replication and LV infection. To date, there have been no reports mapping major histocompatibility complex (MHC) class I-binding CTL epitopes for LV. Using computer-assisted algorithms, we identified five HLA-A2.1-binding peptides of LV glycoprotein (GP) and two peptides from LV nucleoprotein (NP). Synthesized peptides were examined for their ability to bind to MHC class I molecules using a flow cytometric assay that measures peptide stabilization of class I. Three of the LV-GP peptides tested (LLGTFTWTL, SLYKGVYEL, and YLISIFLHL) stabilized HLA-A2. The LV-NP peptides tested failed to stabilize this HLA-A2. We then investigated the ability of the HLA-A2-binding LV-GP peptides to generate peptide-specific CTLs in HLA-A2.1 transgenic mice. Functional assays used to confirm CTL activation included gamma interferon enzyme-linked immunospot (ELISPOT) assays and intracellular cytokine staining of CD8<jats:sup>+<\/jats:sup>T cells from peptide-primed mice. CTL assays were also performed to verify the cytolytic activity of peptide-pulsed target cells. Each of the LV-GP peptides induced CTL responses in HLA-A2-transgenic mice. MHC class I tetramers prepared using one LV-GP peptide that showed the highest cytolytic index (LLGTFTWTL) confirmed that peptide-binding CD8<jats:sup>+<\/jats:sup>T cells were present in pooled lymphocytes harvested from peptide-primed mice. These findings provide direct evidence for the existence of LV-derived GP epitopes that may be useful in the development of protective immunogens for this hemorrhagic virus.<\/jats:p>","DOI":"10.1128\/cdli.12.10.1223-1230.2005","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T18:48:14Z","timestamp":1128624494000},"page":"1223-1230","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["Lassa Fever Virus Peptides Predicted by Computational Analysis Induce Epitope-Specific Cytotoxic-T-Lymphocyte Responses in HLA-A2.1 Transgenic Mice"],"prefix":"10.1128","volume":"12","author":[{"given":"Agnieszka","family":"Boesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnan","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Coico","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, City University of New York Medical School, New York, New York 10031"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5284.94"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.172.5.2861","volume":"172","year":"2004","unstructured":"Baize, S., J. Kaplon, C. Faure, D. Pannetier, M.-C. Georges-Courbot, and V. Deubel. 2004. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol.172:2861-2869.","journal-title":"J. Immunol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/bioinformatics\/btg055","volume":"19","year":"2003","unstructured":"Bhasin, M., H. Singh, and G. P. S. Raghava. 2003. MHCBN: a comprehensive database of MHC binding and non-binding peptides. Bioinformatics19:665-666.","journal-title":"Bioinformatics"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0166-3542(02)00201-2","volume":"57","year":"2003","unstructured":"Drosten, C., B. M. Kummerer, H. Schmitz, and S. Gunther. 2003. Molecular diagnostics of viral hemorrhagic fevers. Antivir. Res.57:61-87.","journal-title":"Antivir. Res."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/intimm\/5.11.1489","volume":"5","year":"1993","unstructured":"Eberl, G., A. Sabbatini, C. Servis, P. Romero, J. L. Maryanski, and G. Corradin. 1993. MHC class I H-2kd-restricted antigenic peptides: additional constraints for the binding motif. Int. Immunol.5:1489-1492.","journal-title":"Int. Immunol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0161-5890(94)90155-4","volume":"31","year":"1994","unstructured":"Feltkamp, M. C., M. P. M. Vierboom, W. M. Kast, and C. J. Melief. 1994. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity. Mol. Immunol.31:1391-1401.","journal-title":"Mol. Immunol."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.15.6777-6783.2000"},{"key":"e_1_3_2_9_2","first-page":"6.21.1","year":"2002","unstructured":"Foster, B., and C. Prussin. 2002. Detection of intracellular cytokines by flow cytometry, p. 6.21.1-6.24.15. In J. Coligan et al. (ed.), Current protocols in immunology. John Wiley & Sons Inc., Hoboken, N.J.","journal-title":"Current protocols in immunology"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1016\/S0264-410X(02)00300-6","volume":"20","year":"2002","unstructured":"Hilleman, M. R. 2002. Overview: cause and prevention in biowarfare and bioterrorism. Vaccine20:3055-3067.","journal-title":"Vaccine"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1099\/vir.0.80183-0","volume":"85","year":"2004","unstructured":"Huang, Y. H., M. H. Tao, C. P. Hu, W. J. Syu, and J. C. Wu. 2004. Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virus. J. Gen. Virol.85:3089-3098.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.23.11418-11421.2000"},{"key":"e_1_3_2_13_2","first-page":"5223","volume":"60","year":"2000","unstructured":"Lu, J., and E. Celis. 2000. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes. Cancer Res.60:5223-5227.","journal-title":"Cancer Res."},{"key":"e_1_3_2_14_2","first-page":"7.14.1","year":"1996","unstructured":"Lycke, N. Y., and R. F. Coico. 1996. ELISPOT assay for measurement of antigen-specific and polyclonal antibody responses, p. 7.14.1-7.14.7. In J. Coligan et al. (ed.), Current protocols in immunology. John Wiley & Sons Inc., Hoboken, N.J.","journal-title":"Current protocols in immunology"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","volume":"314","year":"1986","unstructured":"McCormick, J. B., I. J. King, P. A. Webb, C. L. Scribner, R. B. Craven, K. M. Johnson, L. H. Elliott, and R. Belmont-Williams. 1986. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med.314:20-26.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","volume":"155","year":"1987","unstructured":"McCormick, J. B., P. A. Webb, K. M. Krebs, K. M. Johnson, and E. S. Smith. 1987. A prospective study of the epidemiology and ecology of Lassa fever. J. Infect. Dis.155:437-444.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","volume":"155","year":"1987","unstructured":"McCormick, J. B., I. J. King, P. A. Webb, K. M. Johnson, R. O'Sullivan, E. S. Smith, S. Trippel, and T. C. Tong. 1987. A case-control study of the clinical diagnosis and course of Lassa fever. J. Infect. Dis.155:445-455.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2567.2002.01424.x","volume":"106","year":"2002","unstructured":"Micheletti, F., P. Monini, C. Fortini, P. Rimessi, M. Bazzaro, M. Andreoni, M. Giuliani, S. Traniello, B. Ensoli, R. Gavioli. 2002. Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8. Immunology106:395-403.","journal-title":"Immunology"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/eji.1830230603","volume":"23","year":"1993","unstructured":"Nijman, H. W., J. G. Houbiers, M. P. Vierboom, S. H. van der Burg, J. W. Drijfhout, J. D'Amaro, P. Kenemans, C. J. Melief, and W. M. Kast. 1993. Identification of peptide sequences that potentially trigger HLA-A2.1 restricted cytotoxic T lymphocytes. Eur. J. Immunol.23:1215-1219.","journal-title":"Eur. J. Immunol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.152.1.163","volume":"152","year":"1994","unstructured":"Parker, K. C., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol.152:163-175.","journal-title":"J. Immunol."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.297.6648.584","volume":"297","year":"1988","unstructured":"Price, M. E., S. P. Fischer-Hoch, R. B. Craven, and J. B. McCormick. 1988. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. Br. Med. J.297:584-587.","journal-title":"Br. Med. J."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002510050595"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0092-8674(93)90472-3","volume":"74","year":"1993","unstructured":"Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell74:929-937.","journal-title":"Cell"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1286-4579(01)01508-8","volume":"4","year":"2002","unstructured":"Schmitz, H., B. Kohler, T. Laue, C. Drosten, P. J. Veldkamp, S. Gunther, P. Emmerich, H. P. Geisen, K. Fleischer, M. F. Beersma, and A. Hoerauf. 2002. Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect.4:43-50.","journal-title":"Microbes Infect."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.4049\/jimmunol.153.12.5586","volume":"153","year":"1994","unstructured":"Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. M. Melief, C. Oseroff, L. Yuan, J. Ruppert, J. Sidney, M. D. Guercio, S. Southwood, R. T. Kubo, R. W. Chestnut, H. M. Grey, and F. V. Chisari. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol.153:5586-5592.","journal-title":"J. Immunol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virol.2003.09.016","volume":"318","year":"2004","unstructured":"Simmons, G., A. Lee, A. J. Rennekamp, X. Fan, P. Bates, and H. Shen. 2004. Identification of murine T-cell epitopes in Ebola virus nucleoprotein. Virology318:224-230.","journal-title":"Virology"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4049\/jimmunol.168.1.379","volume":"168","year":"2002","unstructured":"Singh, R. A., L. Wu, M. A. Barry. 2002. Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine. J. Immunol.168:379-391.","journal-title":"J. Immunol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/1097-0215(20000801)87:3<399::AID-IJC14>3.0.CO;2-9","volume":"87","year":"2000","unstructured":"Sun, Y., M. Song, S. Stevanovic, C. Jankowiak, A. Paschen, H. G. Rammensee, and D. Schadendorf. 2000. Identification of a new HLA-A(*)0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen. Int. J. Cancer87:399-404.","journal-title":"Int. J. Cancer"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.5.2186-2192.2000"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.virol.2003.12.013","volume":"321","year":"2004","unstructured":"ter Meulen, J., M. Badusche, J. Satoguina, T. Strecker, O. Lenz, C. Loeliger, M. Sakho, K. Koulemou, L. Koivogui, and A. Hoerauf. 2004. Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones. Virology321:134-143.","journal-title":"Virology"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/jmv.20023","volume":"72","year":"2004","unstructured":"Turcanova, V., and P. Hollsberg. 2004. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein. J. Med. Virol.72:635-645.","journal-title":"J. Med. Virol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1074-7613(00)80066-7","volume":"10","year":"1999","unstructured":"Vonderheide, R. H., W. C. Hahn, J. L. Schultze, and L. M. Nadler. 1999. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity10:673-679.","journal-title":"Immunity"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/eji.1830221209","volume":"22","year":"1992","unstructured":"Zhou, X., U. M. Abdel Motal, L. Berg, and M. Jondal. 1992. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. Eur. J. Immunol.22:3085-3090.","journal-title":"Eur. J. Immunol."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.12.10.1223-1230.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.12.10.1223-1230.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:38:06Z","timestamp":1683247086000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.12.10.1223-1230.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1128\/CDLI.12.10.1223-1230.2005"],"URL":"https:\/\/doi.org\/10.1128\/cdli.12.10.1223-1230.2005","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"2005-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-06-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}